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Calcium Supplementation Does Not Alter  
Lipid Oxidation or Lipolysis in  
Overweight/Obese Women
Vanitha Sampath1, Peter J. Havel2 and Janet C. King2,3
Based on cell culture and studies in mice, increased dietary calcium appears to stimulate lipolysis and could possibly 
reduce body adiposity through hormonal influences on adipocyte calcium uptake. In this study, we investigated the 
effects of 1,500 mg supplemental calcium daily for 3 months on hormones regulating calcium and energy metabolism 
and rates of lipid oxidation and lipolysis in overweight women. Fifteen overweight (BMI > 25 kg/m2) premenopausal 
women were supplemented with 1,500 mg of calcium, as CaCO3, per day for 3 months while maintaining their 
usual diets and activity levels. Baseline and endpoint measurements were obtained after the subjects consumed 
a standardized 25% fat diet for 4 days. Lipid oxidation was measured by indirect calorimetry, lipolysis by infusion 
of deuterated glycerol, and body fat by dual-energy X-ray absorptiometry. Urinary calcium, circulating levels of 
hormones involved in energy and lipid metabolism (insulin, leptin, and adiponectin) or calcium metabolism (25(OH)
D, 1,25(OH)2D), and parathyroid hormone (PTH)) were also measured. Urinary levels of calcium (P = 0.005) increased 
and 1,25(OH)2D declined (P = 0.03). However other parameters, including body weight, body fat, PTH, insulin, leptin, 
adiponectin, 25(OH)D, as well as rates of lipid oxidation and lipolysis were not altered by calcium supplementation. 
Calcium supplementation for 3 months increased urinary calcium excretion, decreased circulating levels of 
1,25(OH)2-D, but had no effect on rates of lipid oxidation or lipolysis, in these overweight women.
Obesity (2008) 16, 2400–2404. doi:10.1038/oby.2008.380
INTRODUCTION
The prevalence of obesity in adults and children has increased 
markedly over the past several decades. Thus, it is not surpris-
ing that a potential role for dietary calcium in regulating energy 
metabolism and body fat has attracted considerable attention 
(1). Epidemiological, cross-sectional, and longitudinal stud-
ies have all reported an inverse relationship between calcium 
intake and body fat in men, women, and children (2–5). In 
general, the loss of fat was greatest, and more fat was lost from 
the abdominal area if the source of dietary calcium was from 
dairy products (1,3).
The reported effects of dietary calcium on body weight and 
fat are not consistent, however, in all human studies. Increased 
dietary calcium/dairy foods did not affect body weight or fat 
in 50 overweight men and women (6), and in a double-blind, 
randomized, placebo-controlled trial of 100 women supple-
mented with 1,000 mg/day of calcium during a 25-week energy-
restricted diet, calcium did not affect the amount of weight or 
fat lost (7). Results from animal studies are also inconsistent. 
Shi et al. (8) reported that mice expressing agouti protein in 
their white fat lost more weight during an energy-restricted, 
high-calcium diet compared to the same degree of energy 
restriction, with low calcium. Similarly Papakonstantinou et 
al. reported that rats fed high-calcium diet gained significantly 
less weight than control animals (9). In contrast, another group 
studying calcium and weight loss in mice consuming an ad libi-
tum diet did not observe a significant effect of a high-calcium 
diet (10).
Although a beneficial effect of calcium and low-fat dairy 
products on body weight could provide a nutritionally sound 
way to promote weight loss, such recommendations have not 
been made, in part because of the conflicting results discussed 
above, and because the underlying mechanisms that might 
be involved in the effects of dietary calcium on body weight/
adiposity are poorly understood (1). Several potential mech-
anisms have been proposed. First, high intakes of calcium 
may promote the saponification of dietary fat in the intestine 
thereby making fat unavailable for absorption. Jacobsen et al. 
(11) recently reported that increasing dietary calcium from 
500 to 1,800 mg/day caused an increase in fecal fat content 
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and fecal energy loss (~350 kJ/day). However, the increased 
fecal energy loss was not associated with a decrease in weight 
or body fat loss. Second, endocrine effects resulting from 
higher calcium intake may stimulate adipocyte lipolysis while 
reducing lipogenesis. Zemel have reported that an increase in 
dietary calcium downregulated parathyroid hormone (PTH) 
and 1,25(OH)2 vitamin D (calcitriol), which decreased adi-
pocyte calcium uptake and inhibited fatty acid synthesis and 
stimulated lipolysis in cultured adipocytes and in mice. A 
third proposed mechanism suggests that dairy protein affects 
the relationship between dietary calcium and weight loss. For 
example, inhibitors of angiotensin-I-converting enzyme pres-
ent in whey protein might inhibit angiotensin-II stimulation 
of adipocyte lipogenesis (12). However, compelling evidence 
that any of these three proposed mechanisms is operative in 
humans or experimental animals is quite limited.
To investigate the effects of dietary calcium supplementation 
on energy homeostasis, carbohydrate and fat metabolism in 
humans, we administered 1,500 mg/day supplemental calcium 
for 3 months to 15 overweight/obese women and measured 
rates of lipolysis in adipose tissue, whole-body lipid oxidation, 
as well as circulating concentrations of several hormones that 
might be involved in the proposed metabolic effects of calcium 
supplementation.
METHODS AND PROCEDURES
Human subjects
Fifteen volunteers were recruited by advertisement. Protocols were 
approved by the University of California at San Francisco, University of 
California at Davis, and the University of California at Berkeley com-
mittees on Human Research. Subjects gave written informed consent 
before enrollment. Subjects had no history of medical illnesses, showed 
no abnormalities on screening physical examination and laboratory 
testing, had BMIs >25 kg/m2, and had normal serum glucose levels. 
Enrollment was restricted to young women, because they represent 
a population with concern about maintaining a healthy body weight. 
Women were excluded if they self-reported any of the following: ciga-
rette smoking, regular use of calcium supplements, previous gestational 
diabetes, irregular menses, or regular aerobic physical activity, i.e., walk 
or jog >6 miles/week. A dietary questionnaire (developed by L. Herraiz 
and D. Dare, dietitians at the General Clinical Research Center (GCRC) 
at San Francisco General Hospital) was used to estimate usual calcium 
intake. Women with intakes >850 mg/day were excluded from the 
study.
Study design
The study was a 3-month calcium supplementation trial with a set of 
baseline and endpoint clinical measurements performed at the begin-
ning and end of the study. The women lived at home during the calcium 
supplementation period and were instructed to maintain their usual 
physical activity and dietary patterns. Immediately after the baseline 
measurements, a 3-month supplementation period with 1.5 g calcium/
day was initiated. The subjects consumed five 300 mg calcium carbon-
ate tablets (TUMS E-X) daily with meals (three in the morning and two 
in the evening). Five tablets were packed for each day in 12 weekly pill 
boxes for the 3-month supplementation period. The pill boxes contain-
ing calcium tablets were collected at the end of the study and the com-
pliance was excellent. More than 95% of the pills were consumed.
All clinical procedures were conducted in the GCRC at San Francisco 
General Hospital during the luteal phase of each woman’s menstrual cycle 
(based on subject histories). Before each measurement, a standardized, 
25% fat diet was consumed for 4 days at home (Figures 1 and 2) to assure 
that the women were consuming similar amounts of dietary fat before 
measuring rates of lipolysis. The diet was based on the food preferences 
and usual calcium intake of each subject. Energy was adjusted to recom-
mended levels (13); the macronutrient distribution of energy was 60% as 
carbohydrate, 25% as fat, and 15% as protein. Meals were standardized 
from day 1 through the end of the measurements/sample collections on 
day 4. Subjects checked into the GCRC between 4:00 and 5:00 pm on day 
3 and were discharged at ~1:00 pm on day 4.
Isotope infusion, clinical measurements,  
and sample collection
Subjects fasted from 6:00 pm on the evening of day 3 until 8:00 am 
on day 4. A baseline blood sample was obtained at 3:45 am on day 4. 
Between 4:00 and 8:00 am, 1,1,2,3,3-[2H5] glycerol was infused at a rate 
of 0.11 µmol/kg/min into an indwelling catheter placed in an antecu-
bital vein at a volume rate of 125 ml/h. The isotope (Isotec, Miamisburg, 
OH) was highly enriched (≥98%) and was tested for sterility and non-
pyrogenicity before infusion. Blood samples were collected at 7:00 am 
for clinical and stable isotope measurements; additional samples col-
lected at 7:30, 7:45, and 8:00 am were used to measure the dilution of 
stable isotopes.
Whole-body lipid oxidation, nonprotein respiratory quotient 
(NPRQ), and resting energy expenditure were measured by indirect 
calorimetry using a Deltatrac metabolic cart (Sensor Medix, Yorba 
Linda, CA) in the hooded mode on day 4 at 7:30 am (immediately 
preceding breakfast). Whole-body lipid oxidation, NPRQ, and resting 
energy expenditure were calculated using the following formulas: (i) 
whole-body lipid oxidation (mg/kg/min) = 1.689 × (l/min oxygen – l/
min carbon dioxide) – 0.324 × g/min urinary N × 1/kg body weight × 
1,000; (ii) NPRQ = (l/min CO2 – (g/min urinary N × 6.25 × 0.774))/(l/
min oxygen – (g/min urinary N × 6.25 × 0.966)); (iii) resting energy 
expenditure (kcal/min) = ((4.686 + (1.096 × (NPRQ–0.707))) × (l/min 
Day 1 Day 2 Day 3 Day 4
Standardized diet
GCRC stay
24-hour Urine collection
Figure 1 Baseline and endpoint schedule (days 1–4). GCRC, General 
Clinical Research Center.
Isotope infusion
3 
AM
4 
AM
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8 
AM
9 
AM
10
 A
M
12
 P
M
11
 A
M
6 
AM
7 
AM
1 
PM
Blood draw
3-h Urine collection24-h urine collection
(continued from day 3)
Breakfast
Check out of GCRC
Indirect calorimetry
Figure 2 Day 4 schedule of procedures. GCRC, General Clinical 
Research Center.
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oxygen – (g/min urinary N × 6.25 × 0.966))) + 4.6 × (g/min urinary 
N × 6.25 × 0.966). Expired air was sampled continuously during the 
30-min measurement. The error in oxygen and carbon dioxide reading 
was under 8%. A 3-h urine sample was obtained from each subject from 
6:00 to 9:00 am for estimating urea nitrogen and determining NPRQ.
A 24-h urine sample was obtained from each subject, collected from 
the morning of day 3 to the morning of day 4 and used for the measure-
ment of urinary calcium.
Body fat was determined using a whole-body dual-energy X-ray 
absorptiometry scan (System 6781, Model DPX Plus, software version 
3.65; Lunar Radiation, Madison, WI) at the GCRC. The scan was per-
formed within a week of the infusion day.
Isolation of metabolites and stable isotope analysis
Because adipose tissue lacks the enzyme glycerol kinase which phos-
phorylates glycerol released during intracellular lipolysis, glycerol must 
be released into circulation and transported to the liver for phosphory-
lation. The glycerol released from adipose tissue dilutes the infused glyc-
erol isotope and provides a means of estimating the rate of whole-body 
lipolysis (14). Glycerol was isolated from the plasma by chromatogra-
phy on two superimposed anion and cation columns after deproteini-
zation with 7% perchloric acid and then centrifuged. The supernatant 
containing glycerol was neutralized, isolated by passing through cation 
and anion resins (15), frozen, and then lyophilized. The dry powder 
was reconstituted with 600 µl of methanol and dried under N2. The ali-
quot was then incubated for 15 min at room temperature after adding 
100 µl of acetic anhydride/pyridine (2:1 vol/vol) solution. The solution 
was dried again under N2 and the dry residue was dissolved in 100 µl of 
ethyl acetate which converted it to glycerol triacetate to increase volatil-
ity and thermal stability for gas chromatography–mass spectrometry 
(model 5890; Hewlett-Packard, Palo Alto, CA) analysis.
Glycerol triacetate was analyzed with a DB-225 by chemical ioniza-
tion (16). Selective ion-monitoring representing mass M0 and M1 was 
159 m/z and 164 m/z, and enrichments were determined by comparison 
of standard curves of 1,1,2,3,3-[2H5] glycerol. The rate of appearance of 
glycerol (Ra glycerol) was calculated as follows (17):
Ra (μg/kg/min) = (RI/glycerol enrichment) – RI, where RI equals infu-
sate glycerol (μg)/weight of subject (kg) × time of infusion (240 min).
Clinical sample analyses
Serum 1,25(OH)2D and 25(OH)D were analyzed by competitive 
enzyme immunoassays (Alpco diagnostics, Windham, NH). A solid-
phase, two-site chemiluminescent enzyme–labeled immunometric 
assay was used for the determination of intact PTH (Diagnostics prod-
ucts, Los Angeles, CA). Serum insulin was measured using an immu-
nometric assay (Diagnostics products, Los Angeles, CA). Leptin and 
adiponectin were measured using radioimmunoassay (Linco Research, 
St. Charles, MO). The percent error for the biochemical measurements 
for PTH, 25(OH)D, 1,25(OH)2D, adiponectin, leptin, and insulin are 4, 
10, 7, 1, 6, and 4 respectively.
Urinary calcium was measured using Inductively Coupled Plasma–
Atomic Emission Spectroscopy (Vista; Varian, Walnut Creek, CA). 
Urinary urea nitrogen and creatinine were determined by enzymatic 
colorimetric determination (VITROS 950AT; Ortho-clinical diagnos-
tics, Rochester, NY) at the GCRC clinical laboratories.
Statistical analysis
Data are presented as means ± s.d. Relative percent changes were calcu-
lated by subtracting the value of the endpoint measurement from that 
the baseline measurement and multiplying by 100. Statistical analyses 
(Statistical Analysis System (SAS), PC version 8.2; SAS Institute, Cary, 
NC) using paired t-tests were performed to test for differences in the 
physiological responses between baseline and endpoint measurements. 
Correlations were calculated to determine the association between 
rates of lipolysis and lipid oxidation and hormone concentrations. 
Differences were considered statistically significant at P < 0.05.
RESULTS
The characteristics of the participants are described in Table 1. 
BMIs of the women ranged from 25 to 33; three subjects had 
BMI >30. The percent body fat averaged 38% (range: 27–46%); 
percent body fat of four women exceeded 40%. Calcium intakes 
averaged 616 mg/day.
Measures of lipid metabolism such as body fat, Ra glycerol, 
and whole-body lipid oxidation, did not change significantly 
after 12 weeks of calcium supplementation (Table 2). No change 
Table 1 Characteristics of study participants
Characteristics
n 15
Age (years) 29 ± 6
Height (m) 1.64 ± 0.07
Body weight (kg) 74.4 ± 10.0
Body fat (kg) 27.7 ± 6.0
Percent body fat 38.1 ± 5.5
BMI (kg/m2) 27.8 ± 2.7
Calcium intake (mg/day) 616 ± 211
Data are presented as mean ± s.d.
Table 2 Effect of calcium supplementation on body weight, 
body fat, rates of lipolysis, and whole-body lipid oxidation
Measurement Baseline Endpoint P
Body weight (kg) 74.4 ± 10.0 73.8 ± 11.8 NS
Body fat (kg) 27.7 ± 6.0 26.6 ± 6.4 NS
Ra glycerol (µmol/kg/min) 3.49 ± 1.53 3.71 ± 1.42 NS
Whole-body lipid oxidation-
fasting (mg/kg/min)
0.86 ± 0.25 0.91 ± 0.18 NS
Fasting energy expenditure 
(kcal/day)
1,470 ± 167 1,498 ± 189 NS
Fasting NPRQ 0.82 ± 0.05 0.82 ± 0.03 NS
Data are presented in mean ± s.d.
NPRQ, nonprotein respiratory quotient; NS, nonsignificant.
Table 3 Changes in metabolic hormones and serum/
urinary minerals in study subjects before and after calcium 
supplementation
Measurement Baseline Endpoint P
1,25(OH)2D (pg/ml) 49.2 ± 32.5 38.0 ± 22.6 0.03
PTH (pg/ml) 22.5 ± 7.5 20.5 ± 6.0 NS
25(OH)D (nmol/l) 45.1 ± 28.0 48.7 ± 24.3 NS
Insulin (µIU/ml) 12.4 ± 6.7 12.2 ± 3.6 NS
Leptin (ng/ml) 29.1 ± 10.3 26.1 ± 10.2 NS
Adiponectin (µg/ml) 11.0 ± 3.7 11.3 ± 3.7 NS
24-h Urinary calcium 
excretion (mg/24 h)
77.7 ± 49.2 96.1 ± 42.9 0.005
Data are presented in mean ± s.d.
NS, nonsignificant; PTH, parathyroid hormone.
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hypertensive, it is possible that differences in the popula-
tions, including gender, studied may account for the different 
responses to calcium supplementation observed between the 
two studies. To our knowledge, there are no published stud-
ies investigating whether circulating leptin and adiponectin 
concentrations are influenced by increased calcium intakes 
in humans. Neither the small increase of adiponectin nor the 
decrease of leptin observed in the study was significant.
Twenty four–hour urinary calcium increased by 24%, indi-
cating compliance with calcium supplementation. In addi-
tion, body weight or body fat did not decrease after 12 weeks 
of calcium supplementation. This was not unexpected because 
the study was not designed to be powered to detect changes 
of body weight or adiposity. Data analyzed by Heaney et al. 
(23) suggest that for both middle aged and older women, a 
calcium intake difference of 300 mg/day is associated with 
weight loss in the range of 0.11–0.16 kg/year. Extrapolating 
this data to include younger women, an addition of 1,500 mg 
of calcium a day for 3 months could lead to weight losses 
of up to 0.20 kg. This marginal weight loss would not be 
expected to be statistically significant in a study that included 
only 15 subjects.
Although we observed no effects of increased calcium 
intakes on lipolysis, it is possible that other factors that were 
not taken into consideration in the present study may have 
influenced the outcome. The subjects in the study had on aver-
age, fasting glucose, PTH, 25(OH)D, and insulin levels close to 
the lower end of the normal range. It is possible that changes in 
the endpoints measured may be more discernable among indi-
viduals with chronically elevated levels of these hormones and 
metabolites (indicating a more metabolically impaired state). 
The minimum amount of dietary calcium required to induce a 
metabolic shift in substrate utilization and energy expenditure 
may be an important factor in determining these relationships. 
Currently available data are insufficient to define this threshold. 
It is possible that the subject’s mean baseline calcium intakes 
of 616 mg/day in this study were above this threshold value. 
A third factor that may play an important role is the source 
of calcium in the diet. Zemel (24) reported that dairy calcium 
sources have a greater effect than nondairy calcium sources, 
and they have hypothesized that other factors present in milk/
dairy products contribute to or work together with calcium in 
the reported effects dairy foods to induce weight loss.
In conclusion, the present study conducted in young over-
weight to obese healthy women did not replicate previous 
findings reported in transgenic agouti mice (8) that increased 
dietary calcium independently increases rates of lipolysis. We 
found that increased calcium intakes (1,500 mg of calcium 
a day for 3 months) in overweight or obese women did not 
shift lipid metabolism in a manner that would be expected to 
result in weight loss over the long-term (i.e., toward lipolysis) 
through effects on the PTH/1,25(OH)2D axis.
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in body weight was observed either. Similarly, there were no 
significant changes of resting energy expenditure or NPRQ.
Plasma concentrations of the calciotropic hormone 
1,25(OH)2D decreased by 23% from 49.2 ± 32.5 to 38.0 ± 22.6 
pg/ml (P = 0.03), however, there were no significant changes 
in either PTH or 25(OH)D. Similarly, there were no significant 
changes in the circulating concentrations of the hormones, 
insulin, adiponectin, or leptin, which are known to be involved 
in the regulation of lipid metabolism. Twenty four–hour uri-
nary calcium excretion increased significantly by 24% from 
77.7 ± 49.2 to 96.1 ± 42.9 mg/24 h (P = 0.005) after calcium 
supplementation (Table 3).
DISCUSSION
Supplementation with 1,500 mg of calcium a day for 3 months 
in young overweight or obese women statistically increased 
24-h urinary calcium. A significant decrease in 1,25(OH)2D 
was also observed. However, no significant effects on rates 
of lipolysis, whole-body lipid oxidation, whole-body energy 
expenditure/NPRQ, body weight, body fat, PTH, 25(OH)D, 
insulin, leptin, or adiponectin concentrations were observed. 
Overall, the results of this study do not support the hypoth-
esis that supplementation with 1,500 mg of calcium/day for 
3 months in healthy overweight or obese women increases 
lipolysis.
This is the first study to date to investigate the effects of 
increased calcium intakes on rates of lipolysis (Ra glycerol) in 
human subjects. The rate of glycerol appearance (Ra glycerol) 
was unchanged during calcium supplementation suggest-
ing that lipolysis is not influenced by a substantial increase 
in dietary calcium. Whole-body lipid oxidation, measured by 
indirect calorimetry, before and after calcium supplementation 
was also unchanged. Melanson et al. (18) reported that acute 
total and acute dairy calcium intakes (i.e., calcium intakes in 
the past 24 h) were positively correlated with 24-h lipid oxida-
tion measured in a whole room indirect calorimeter. However, 
they found no relationship between habitual total and dairy 
calcium intake. It is possible that acute changes of calcium 
intake alter the rates of lipid oxidation, but these rates return to 
a state of equilibrium within a relatively short period of time.
Of the hormones measured, only plasma 1,25(OH)2D, which 
decreased by 23%, was significantly changed by calcium sup-
plementation. Given that the initial plasma PTH concentra-
tions in the subjects were in the low–normal range, it seems 
unlikely that calcium supplementation would cause a further 
decline of PTH (19). Another possibility is that the 10-h lag 
period between taking the calcium supplement and blood 
sampling decreased the ability to detect effects on PTH. Intact 
PTH has a half-life of only a few minutes (20), and in a recent 
study by Ortolani et al., a maximal decrease of PTH secretion 
was observed 2 h after calcium intake (21).
In the present study, fasting serum insulin concentrations 
were unchanged during calcium supplementation. This dif-
fers from the results reported by Sanchez et al. (22) who 
studied nondiabetic, hypertensive older men (mean age 45 
years). Because none of the women in the present study were 
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